Home
Adicet Bio

Adicet Bio Market Share Analysis for May 2026

adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta t cell therapies for cancer and other diseases.

Health > Biotechnology and Pharmaceuticals

Domainadicetbio.com

Year Founded2014

Employees51 - 200

Annual Revenue$15M - $25M

Adicet Bio

Adicet Bio (including company regionals)

adicetbio.com

See more website traffic and engagement information

Adicet Bio Revenue up to May 2026 is 15M - 25M

revenue generated by Adicet Bio top domains

Adicet Bio top domains revenue over 3 years

Revenue for Adicet Bio top domains

adicetbio.com15M - 25M

See more with Sales Intelligence

Total visits to Adicet Bio's top domains

Understand Adicet Bio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

adicetbio.com5.7K

See more with Sales Intelligence

Avg. visit duration in Adicet Bio's top domains

Analyze Adicet Bio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

adicetbio.com00:01:07

See more with Sales Intelligence

Avg. pageviews on Adicet Bio's top domains

See how Adicet Bio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

adicetbio.com2.16

See more with Sales Intelligence

Adicet Bio top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Adicet Bio

These are the website technologies, by industry, used by Adicet Bio top domains

Recruitment (2)

Greenhouse

Advertising (1)

PubMatic

Audio Video Media (1)

Vimeo

Conversion & Analytics (1)

Google Analytics

More Technologies

6

See all

News & Signals from Adicet Bio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAdicet Bio Inc. attends event Guggenheim Emerging Outlook: Biotech Summit 2026.Adicet Bio to present at the Guggenheim Emerging Outlook: Biotech Summit 2026.

NewsAdicet Bio Inc. attends event H.C. Wainwright 27th Annual Global Investment Conference.Adicet Bio to present at the H.C. Wainwright 27th Annual Global Investment Conference.

NewsAdicet Bio Inc. is developing off-the-shelf T-cell therapies.Auspicious alliance: MaxCyte and Adicet partner to develop off-the-shelf T-cell therapies.